Valuation Update With 7 Day Price Move • 18h
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩47,200, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 351% over the past three years. New Risk • Apr 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Profit margins are more than 30% lower than last year (1.6% net profit margin). Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩32,300, the stock trades at a trailing P/E ratio of 67.3x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 162% over the past three years. Buy Or Sell Opportunity • Apr 02
Now 25% undervalued Over the last 90 days, the stock has risen 47% to ₩30,000. The fair value is estimated to be ₩39,821, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 61%. New Risk • Apr 01
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.6% Last year net profit margin: 3.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Profit margins are more than 30% lower than last year (1.6% net profit margin). Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩24,500, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 87% over the past three years. Annuncio • Mar 13
LTC Co.,Ltd, Annual General Meeting, Mar 27, 2026 LTC Co.,Ltd, Annual General Meeting, Mar 27, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 155, sicheong-ro, gyeonggi-do, hwaseong South Korea Valuation Update With 7 Day Price Move • Feb 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩23,250, the stock trades at a trailing P/E ratio of 24.7x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 113% over the past three years. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩27,200, the stock trades at a trailing P/E ratio of 29x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 174% over the past three years. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₩22,800, the stock trades at a trailing P/E ratio of 23.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 123% over the past three years. Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 10% After last week's 10% share price gain to ₩17,940, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 83% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 23 April 2026. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%). Declared Dividend • Nov 08
Dividend of ₩100.00 announced Dividend of ₩100.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 23rd April 2026 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%. Payout Ratios Payout ratio: 8%. Cash payout ratio: 3%. Annuncio • Nov 07
LTC Co.,Ltd announces Annual dividend, payable on April 23, 2026 LTC Co.,Ltd announced Annual dividend of KRW 100.0000 per share payable on April 23, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Valuation Update With 7 Day Price Move • Oct 28
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩20,600, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 112% over the past three years. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩16,930, the stock trades at a trailing P/E ratio of 14.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 61% over the past three years. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩14,640, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. New Risk • Jul 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₩110.6b market cap, or US$79.5m). Valuation Update With 7 Day Price Move • Jun 26
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩12,250, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 40% over the past three years. Valuation Update With 7 Day Price Move • May 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩11,350, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 3.0% over the past three years. Valuation Update With 7 Day Price Move • Apr 23
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩10,360, the stock trades at a trailing P/E ratio of 9.7x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 4.3% over the past three years. Reported Earnings • Mar 25
Full year 2024 earnings released: EPS: ₩1,088 (vs ₩3,226 loss in FY 2023) Full year 2024 results: EPS: ₩1,088 (up from ₩3,226 loss in FY 2023). Revenue: ₩277.0b (up 144% from FY 2023). Net income: ₩10.1b (up ₩36.6b from FY 2023). Profit margin: 3.6% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Annuncio • Mar 14
LTC Co.,Ltd, Annual General Meeting, Mar 28, 2025 LTC Co.,Ltd, Annual General Meeting, Mar 28, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 387, madobuk-ro, mado-myeon, gyeonggi-do, hwaseong South Korea New Risk • May 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 56% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (12% increase in shares outstanding). New Risk • Mar 15
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩130.2b (US$97.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.2% operating cash flow to total debt). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (₩130.2b market cap, or US$97.9m). New Risk • Dec 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.2% operating cash flow to total debt). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Shareholders have been diluted in the past year (9.9% increase in shares outstanding). Market cap is less than US$100m (₩103.5b market cap, or US$78.8m). Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Annuncio • Feb 18
LTC Co.,Ltd announced that it expects to receive KRW 10 billion in funding LTC Co., Ltd. announced a private placement of round 4 unregistered coupon nonguaranteed undetachable private convertible bond for gross proceeds of KRW 10,000,000,000 on February 17, 2022. The bonds would mature on February 21, 2025. The bonds are fully convertible into common shares of the company at a fixed conversion price of KRW 13,956 per share between the period February 21, 2023 to January 21, 2025. The bonds carry zero Surface interest rate and maturity rate. The transaction has been approved by the board of directors of the company. Upcoming Dividend • Dec 22
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.4%). Reported Earnings • Mar 20
Full year 2020 earnings released: ₩557 loss per share (vs ₩104 profit in FY 2019) The company reported a soft full year result with weaker earnings and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: ₩94.8b (up 3.0% from FY 2019). Net loss: ₩4.03b (down ₩4.79b from profit in FY 2019). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improved over the past week After last week's 41% share price gain to ₩17,400, the stock is trading at a trailing P/E ratio of 64.8x, up from the previous P/E ratio of 46x. This compares to an average P/E of 17x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 30%. Is New 90 Day High Low • Jan 14
New 90-day high: ₩13,650 The company is up 14% from its price of ₩12,000 on 16 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 36% over the same period. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩100.00 Per Share Will be paid on the 17th of April to those who are registered shareholders by the 29th of December. The trailing yield of 0.8% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (0.9%). Is New 90 Day High Low • Oct 26
New 90-day low: ₩11,350 The company is down 13% from its price of ₩13,000 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period. 
